Gastrointestinal diseases (GIDs) are known risk factors of secondary osteoporosis and osteopaenia. These patients, being at increased risk of fracture, are affected at a much younger age than is normally associated with osteoporosis and warrant special consideration.1
The following article is based on presentations by Dr Tobie de Villiers at the recent National Osteoporosis Foundation of South Africa (NOFSA) presentation of the International Society of Clinical Densitometry (ISCD) course on bone densitometry, held in Stellenbosch.
Postmenopausal osteoporosis is common in men and women over the age of 50. In fact, one in three women and one in five men in this age category are at risk of an osteoporotic fracture, according to the International Osteoporosis Foundation (IOF).
Osteoarthritis (OA) is one of the leading causes of disability in the elderly. Changes in the lubricating properties of synovial fluid lead to significant pain and functional disability.
This article is based on a presentation by Prof Sergei Ferrari, chair of the Council of Scientific Advisors of the International Osteoporosis Foundation (IOF).
SPECIALIST FORUM NOVEMBER CPD 2 of 2: How effective are fracture risk tools? When should treatment be started in patients with osteoporosis? What treatment strategies are recommended and what is the role of supplementation?
Efficacy and safety of intra-articular use of hyaluronic acid in the treatment of knee osteoarthritis
MEDICAL CHRONICLE AUGUST CPD 4 of 4: Hyaluronic acid reduces the symptoms and development of osteoarthritis.
SPECIALIST FORUM AUGUST CPD 4 of 4: NSAIDs are the mainstay treatment of osteoarthritis and rheumatoid arthritis, two of the leading causes of morbidity and disability worldwide.